Persist AI

Developing long-lasting drug formulations 50% faster

Y CombinatorWinter 2023ActiveHealthcareDrug Discovery and DeliveryMachine LearningRoboticsMicrofluidicsNanotechnology

What they do

Problem

Pharma companies take around 5 years to develop long-lasting injectable drug formulations for chronic diseases, slowing time-to-market.

Solution

Persist AI uses AI-driven automation to accelerate long-lasting drug formulation development, cutting timelines to about 2 years.

Who it's for

Pharmaceutical companies and drug formulation R&D teams developing long-acting injectable therapies.

Founders

Karthik Raman

Founder

When mom got brain cancer, I used to take her for her "infusions". For 4 hours, we would sit there while drug was being infused into her veins and she had horrible nausea and hair loss. I built Persist to eradicate this horrible experience for future patients. We package drugs so that patients take 1 injection per month or year, without an infusion. This lowers the overall dose the patient receives (reducing side-effects), improves compliance, and quality of life.